Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederthelancet.com
The Lancet
Get the latest updates from The Lancet directly as they happen.
Follow now 134 followers
Latest posts
Last updated 1 day ago
Could enpatoran add to our therapeutic toolbox in SLE?
1 day ago
Systemic lupus erythematosus (SLE) is a clinically and serologically heterogeneous condition in...
RTS,S/AS01 implementation reduces mortality in African children
1 day ago
WHO's approval of the RTS,S/AS01 (Mosquirix) malaria vaccine in 2021 marked a...
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial
1 day ago
In this study of participants with moderate-to-severe SLE, enpatoran improved BICLA response...
Impact of introducing RTS,S/AS01E malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme
1 day ago
Introduction of the RTS,S malaria vaccine in routine immunisation programmes was associated...
Fabricated references: a new threat to editorial integrity
1 day ago
In this issue of The Lancet, Topaz and colleagues1 report the first...
Broadening metrics in the Lancet Countdown on health and climate change – Authors’ reply
1 day ago
We thank Chris Newman for the thoughtful input. We share the interest...
“We don’t want it to happen to others”: suicide in young Māori
1 day ago
Suicide is the leading cause of death in New Zealanders aged 15–19...
Toxicology-informed sequencing to optimise cancer therapy - Authors’ reply
1 day ago
We thank Gang Lv and colleagues for the response to our study.1...
Toxicology-informed sequencing to optimise cancer therapy
1 day ago
We commend David J Lewis and colleagues1 for demonstrating that ibrutinib–rituximab can...
Broadening metrics in the Lancet Countdown on health and climate change
1 day ago
Reading the Lancet Countdown,1 I felt both concern and unease. The evidence...
The pharyngeal sanctuary: a challenge for zoliflodacin
1 day ago
The phase 3 trial by Alison Luckey and colleagues1 validating zoliflodacin marks...
Zoliflodacin: non-inferior, but not equivalent?
1 day ago
We congratulate Alison Luckey and colleagues 1 of the phase 3 zoliflodacin...